PharmaPraxis Announces an Agreement with Brazil’s Ministry of Health to Manufacture Monoclonal Antibodies

April 7, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

RIO DE JANEIRO, Brazil--(BUSINESS WIRE)--PharmaPraxis, from Axis Biotec, Cryopraxis, Silvestre Labs and CellPraxis Group, announces the formalization of an agreement with Brazil's Ministry of Health to manufacture biologic drugs.

Twitter
LinkedIn
Facebook
Email
Print

Alliances South America